Aplenzin 348 MG 24 HR Extended Release Oral Tablet
- RxCUI
- 993569
- RxNorm name
- Aplenzin 348 MG 24 HR Extended Release Oral Tablet
- Display name
- Aplenzin 348 MG 24 HR Extended Release Oral Tablet
- Full name
- Aplenzin 348 MG 24 HR Extended Release Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aplenzin | BUPROPION HYDROBROMIDE | Bausch Health US, LLC | 6494d2d9-0ce4-4126-b1c7-49684395942b | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | 993569 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6494d2d9-0ce4-4126-b1c7-49684395942b | Aplenzin 348 MG 24 HR Extended Release Oral Tablet | SY | 27 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985 | 20260304 |
| 6494d2d9-0ce4-4126-b1c7-49684395942b | 24 HR Aplenzin 348 MG Extended Release Oral Tablet | SY | 27 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985 | 20260304 |
| 6494d2d9-0ce4-4126-b1c7-49684395942b | 24 HR bupropion hydrobromide 348 MG Extended Release Oral Tablet [Aplenzin] | SBD | 27 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985 | 20260304 |
| 6494d2d9-0ce4-4126-b1c7-49684395942b | Aplenzin 348 MG 24HR Extended Release Oral Tablet | PSN | 27 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985 | 20260304 |
| 2315d6e5-144d-4163-9711-f855c759cf8e | Aplenzin 348 MG 24HR Extended Release Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 20110210 |
| 2315d6e5-144d-4163-9711-f855c759cf8e | Aplenzin 348 MG 24 HR Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 20110210 |
| 2315d6e5-144d-4163-9711-f855c759cf8e | 24 HR Aplenzin 348 MG Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 20110210 |
| 2315d6e5-144d-4163-9711-f855c759cf8e | 24 HR bupropion hydrobromide 348 MG Extended Release Oral Tablet [Aplenzin] | SBD | 1 | These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN (bupropion hydrobromide) tablet, film coated, extended release for oral use Initial U.S. Approval: 1985 | 20110210 |